ALK and lung cancer: Interestingly, we found that FAM83A but not FAM83B was downregulated in tumors bearing KRAS mutations (Figure 6C,D) as the EGFR mutation, KRAS mutation, and ALK rearrangement are largely mutually exclusive events in lung cancer [32].